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1. Introduction 
The genome of o-viruses like Semliki Forest virus 
(SFV) and Sindbis virus consists of a single-stranded 
RNA molecule of M, 4-4.5 X lo6 [l-3]. The genes 
coding for the non-structural proteins are located near 
the 5 (capped) terminus of this 42 S RNA, whereas 
the information for the structural proteins, one cap- 
sid and three envelope proteins, is found near the 3’ 
terminus 14-61. 
~thou~ the 42 S SFV genome contains both the 
non-structural and structural protein genes, the struc- 
tural proteins appear to be translated not from 42 S 
mRNA but from a second viral mRNA of 26 S 
[4,7,8]. This 26 S RNA is transcribed independently 
from the 5’ third of the 42 S minus strand in infected 
cells [9]. 
The non-structural proteins encoded by the 42 S 
mRNA, as well as the structural proteins translated 
from the 26 S RNA, appear to be derived from large 
precursor molecules by post-translational cleavage 
[lo]. Therefore, like most (if not all) eukaryotic 
mRNAs the 42 S viral mRNA seems to be monocis- 
tronic. 
However, studies with cell-free systems to which 
the 42 S but no 26 S mRNA was added, suggest he 
existence on 42 S RNA of a second initiation site, 
which acts as a starting point for the synthesis of 
structural proteins. In such systems more than one 
initiating dipeptide [ 1 l] and simultaneous produc- 
tion of both structural and non-structural proteins 
were demonstrated [12-141. In the latter case, how- 
ever, the possibility of post-translational cleavage of a 
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large percursor, initiated at the 5’ terminal site was 
not excluded [12-l 41. 
Here we present further evidence for a two site 
model for initiation of protein synthesis on 42 S 
RNA in cell-free systems: we show that when 42 S 
RNA is added to cell-free fractionated systems 
derived from rabbit reticulocytes. ‘non-structural’ as 
well as structural proteins are produced at a cap-ana- 
logue sensitive and a cap-analogue insensitive site, 
respectively. 
It is important to mention the observation that 
with excess 42 S RNA, initiation of protein synthesis 
occurs predom~~tly at the cap-analogue insensitive 
site, suggesting different affinities of the two sites for 
one or more of the components of the initiating 
machinery. 
2. Materials and methods 
Wild-type SFV was grown on mouse neuroblasto- 
ma cells in minimal essential medium supplemented 
with 3% fetal calf serum. The SFV suspension was 
concentrated 3 times in an Amicon hollow fiber con- 
centrator, type DC2A. The virus was sedimented in a 
SW27 rotor for 2 h at 27 000 rev./min, resuspended 
in BS buffer (0.12 M NaCl, 0.05 M NasBOs, pH 9.0) 
and further purified on a 20-50% sucrose gradient in 
the same buffer in a SW 50.1 rotor for 2 h at 50 000 
rev./mm. The virus-containing gradient fractions were 
supplemented with lithiumdodecylsulfate and 2.mer- 
captoethanol to final cont. 0.5% (w/v) and 5% 
(v/v), respectively. The 42 S RNA was deproteinized 
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twice with a phenol/chloroform mixture (1: l), precip- 
itated with ethanol and dissolved in Hz0 at 1 mg/ml. 
Protein synthesis in a fractionated system, derived 
from reticulocyte lysates was determined as in [15], 
as modified [ 161. A typical 25 4 reaction mixture 
contained: 20 mM Hepes-KOH (pH 7.6), 1 mM ATP, 
0.4 mM GTP, 5 mM creatine phosphate, 1 mM dithio- 
threitol, 0.05 unit creatine kinase, 2 mM Mg-acetate, 
120 mM K-acetate, 100 PM spermine, 0.3 PM [35S]- 
methionine (600 Ci/mmol), 50 PM each of 19 unla- 
beled amino acids, 0.1 and Cl.3 AzW unit of washed 
40 S and 60 S ribosomal subunits, respectively, 0.1 
A 260 unit tRNA, 10 pg crude initiation factors, frac- 
tion A (see [ 15]), 12.5 /.tg fraction B, 7.5 pg fraction 
C and amounts of SFV RNA as indicated. [35S]- 
Methionine incorporation was measured after 30 min 
incubation at 37°C by hot trichloroacetic acid precip- 
itation. Analysis of the polypeptides was performed 
on 12.5% polyacrylamide gels by the method in [ 171. 
After staining, destaining and drying the gels were 
subjected to autoradiography [ 181. 
[3SS]Methionine and m’GpppGm were obtained 
from NEN and PL Biochemicals, respectively. Rabbit 
antiserum was kindly provided by Dr B. A. M. v. d. 
Zeyst, the SFV structural proteins were immunopre- 
cipitated with this antiserum [ 191. 
As shown in fig. 1 the antiserum is virtually mono- 
specific for the capsid protein (C). The figure demon- 
strates that only the viral structural proteins, present 
in SFV-infected BHK-cells, are precipitated by the 
antiserum (fig.1, lanes 3,4), whereas no precipitate 
was formed in uninfected cells (fig.1, lanes 1,2). 
3. Results and discussion 
3.1. Protein synthesis under direction of 42 S SFV 
RNA and the effect of cap-analogue 
Addition of 42 S SFV mRNA to a fractionated 
system for protein synthesis (see section 2) resulted 
in a 20-fold stimulation of amino acid incorporation 
over a background obtained in the absence of added 
SFV RNA. A number of distinct, high molecular 
weight polypeptides was produced (see fig.2,3). In 
these systems, protein synthesis under the direction 
of capped mRNAs, such as 42 S SFV RNA, is inhib- 
ited by the addition of cap-analogues like m’GpppGm 
and m’GpppAm [20-221. However, little effect of 
Fig. 1. Analysis of proteins labeled in SFV-infected BHK cells. 
About lo6 cells were infected with SFV (m.o.i. 50 p.f.u./cell) 
and labeled at 5 -7 h post infection with 20 ~Lci [a’S]methio- 
nine (600 Ci/mmol). Cells were lysed in 150 ~1 Buffer (20 mM 
Tris-HCl (pH 7.4), 1 mM EDTA, 10 mM NaCI, 0.5% 
Triton-X100 and 0.5% 1,5-naphtalene disulfonate) and the 
labeled proteins were subjected to immunoprecipitation and 
SDS-gel electrophoresis as in section 2. (1) Proteins from 
mock-infected cells (450 000 cpm); (2) proteins from 1 precip- 
itable with anti-SFV serum (28 000 cpm); (3) proteins from 
SFV-infected cells (195 000 cpm); (4) proteins from 3 precip- 
itable with anti-SFV serum (71 000 cpm). The gels were 
dried and subjected to autoradiography for 1 h. The arrows 
in the figure mark the position of the viral (precursor) pro- 
teins (cf [4]). 
these analogues is observed with non-capped messen- 
gers [23]. 
Therefore it seemed of interest to determine 
whether the addition of such analogues has any effect 
on the synthesis of proteins directed by 42 S RNA. 
Differences in cap-analogue sensitivity might enable 
us to distinguish between 5’ terminal and internal 
sites. The results of such an experiment are depicted 
in flg.2, which shows the ecfect of m’GpppGm on 
protein synthesis in the presence of varying amounts 
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Fig.2. Effect of varying amounts of 42 S SFV RNA on ‘in vitro’ translation both in the absence and presence of m’GpppGm. (II) 
Total incorporation (in 25 ccl mixtures) of [?3]methionine into proteins in the absence (e-e, A) and presence (o-o, B) of 100 JJM 
m’GpppGm added to cell-free systems as in section 2. (II) Product analysis on a 12.5% SDS gel (autoradiography for 18 h) of 
expt (I). Lane (A): proteins synthesized in the absence of 100 PM m' GpppGm. Lane (B): proteins synthesized in its presence. 
The arrows (1,2,3) indicate the position to which three cap-analogue insensitive polypeptides migrate (MI 33 000, 21 000 and 
16 000). The faint bands of M, 50 000 and 18 000 represent proteins synthesized in the system in the absence of added mRNA. 
of 42 S mRNA. It is clear that at all RNA concentra- 
tions tested, a strong inhibition by m’GpppGm was 
observed (-85%) particularly at low mRNA concen- 
trations (< 2 pg). The effect with higher amounts of 
42 S mRNA, however, was much less severe (-40% 
inhibition with 4 pg RNA) since high concentrations 
of mRNA strongly suppress protein synthesis in the 
absence of cap-analogue, but have little effect in its 
presence (fig.2, curve A+B). Analysis of the products 
synthesized under the different conditions is shown 
in fig.2 (II). 
Two interesting observations can be made: 
1. The synthesis of the majority of the products is 
inhibited by m’GpppGm, which is apparent when 
lanes A and B are compared. However, three poly- 
peptides of Mr 33 000,21 000 and 16 000 (marked 
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1,2 and 3, respectively) are produced without a 
significant effect by m’GpppGm. The sum of 
amino acid incorporation into these three products 
essentially accounts for the cap-analogue insensi- 
tive protein synthesis as represented by curve B 
of fig.2 (I). 
2. The synthesis of the capanalogue insensitive poly- 
peptides 1,2 and 3 is not affected by high levels of 
SFV mRNA, in contrast to the synthesis of all 
cap-analogue sensitive products. 
These results suggest hat 42 S SFV RNA contains 
two initiation sites: a 5’ terminal, cap-analogue sensi- 
tive site, which is preferentially recognized at a low 
mRNA input and an internal, cap-analogue insensitive 
site, predominantly utilized when excess amounts of 
mRNA are added to the assay systems. Other exam- 
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ples of preferential initiation, i.e., one species of 
mRNA out-competing another mRNA, have been 
reported [24-261. The molecular mechanism of such 
mFWA selection is not fully understood, although a 
different dependence of mRNAs for limiting amounts 
of initiation factors such as eIF-4A [24] or eIF4B 
[25,26] has been postulated (see also [27] ). 
3.2. Immunological characterization of translational 
products 
In order to determine whether the capsid protein 
is among the products synthesized under the different 
conditions, anti-SFV serum (see section 2) was added 
to the reaction mixtures and the amount of anti-SFV- 
precipitable products was determined as a function 
of the 42 S RNA concentration. The results of such 
an analysis are shown in fig.3 (I) curve A, B. It is clear 
that at low concentration of 42 S mRNA (< 1 E.cg) 
very little antibody-precipitable protein is made 
(compare curves A and B of fig.3 (I)). However, with 
large amounts of mRNA a considerable portion (40%) 
of the synthesized protein was precipitated by the 
antibody. Gel analysis of the products revealed that 
proteins 1,2 and 3 were almost quantitatively precip- 
itated by the antiserum (fig.3 (II) lane A versus B). 
This result suggests that these three proteins, which 
were initiated at a cap-analogue insensitive, ‘high 
affinity’ site (see fig.2) contain antigenic determinants 
of the capsid protein. Indeed the molecular weight of 
product 1 is in good agreement with the molecular 
II 
1 2 3 4 0 0.5 1.0 20 4.0 
ug SFV-RNA 
Fig.3. Immunological characterization of translational products. (I, e-e, A) Total incorporation (in 25 ~1 mixtures) of [?S]methi- 
onine into proteins as a function of the concentration of 42 S RNA as in the legend to fig.2 (I). (I, o-o, B) Total amounts of radio- 
activity incorporated into anti-SFV serum-precipitable material under these conditions. (II) Product analysis on a 12.5% SDS gel 
(autoradiography for 70 h) of expt (I) (see fig.l,2 and section 2). The arrows indicate the position to which three anti-SFV serum- 
precipitable polypeptides migrate (MI 33 000, 21 000 and 16 000). 
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weight reported for the capsid protein [28,29]. 
Furthermore, partial proteolytic digestion according 
to [30] of capsid protein and product 1 by Staphylo- 
coccus aureus protease (VS) yielded identical frag- 
ments, whereas products 2 and 3 appeared to be N- 
terminal fragments (results not shown). These results 
indicate that the internal, cap-analogue insensitive site 
(fig.2) is the starting point for the synthesis of struc- 
tural proteins, whereas the non-structural proteins are 
initiated at the 5’ terminal, cap-analogue sensitive site. 
The extent of the production of structural polypep- 
tides depends on the 42 S RNA concentration used 
(fig.2,3), a fact which might explain some of the 
conflicting results reported [ 12- 14,3 l-341. 
3.3. Does the in ternal site originate from RNase 
action? 
The possibility remains that the expression of the 
internal site is triggered by RNase action on 42 S 
SFV RNA, although it seems more likely that such an 
event would result in spurious initiation at many 
cryptic sites on the mRNA rather than the selective 
production of structural proteins [35]. To check this 
a pulse experiment was carried out in which only 
those products were labeled which were synthesized 
during the first 1.5 min incubation, both with low 
(1 fig) and high (4 pg) amounts of 42 S RNA. The 
results are shown in fig.4. It is clear that the % of 
antiserum-precipitable products, labeled during the 
first 1.5 min, when the mRNA is still virtually intact, 
is essentially the same as found in the experiment of 
fig.3, in which the products were labeled for the full 
30 min, during which considerable mRNA fragmenta- 
tion occurs, i.e., -10% of structural proteins at low 
versus -40% of structural proteins at high 42 S RNA 
concentration. It is also obvious from this figure that 
Fig.4. Pulse-chase xperiment at low and high 42 S RNA concentration. Proteins were labeled from O-1.5 min with 50 &i [?S]- 
methionine (600 Ci/mmol) in assay conditions for protein synthesis as in section 2, after which the incubation was continued for 
5 min with excess non-radioactive methionine (16 mM). Total incorporation of radioactivity into translational products (A) and 
immunoprecipitable polypeptides (B) was measured as in section 2. Amounts of radioactivity obtained in the absence of mRNA 
were subtracted. The bands ofM, -50 000 and -18 000 are very rapidly labeled as compared with the labeling kinetics of the 
virus-specific proteins. For that reason the intensities of these bands exceed those of the viral proteins after short incubation times. 
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product 3, the smalllest N-terminal part of the capsid 
protein, is the first protein to be labeled. Further- 
more, addition of SFV mRNA to a protein syn- 
thesizing system derived from wheat-germ [36], in 
which the mRNA remains undegraded for > 15 min, 
also results in the synthesis of products 1,2 and 3 in 
the same relative amounts as observed in the rabbit 
reticulocyte system (results not shown). These experi- 
ments strongly, although not conclusively, argue 
against the possibility of the second site being poten- 
tiated by a random RNase action. 
3 4. Conclusion 
We conclude that 42 S RNA contains two sites for 
initiation of protein synthesis: 
(1) A 5’ terminal cap-analogue sensitive site which 
acts as a starting point for non-structural proteins 
(2) An internal, cap-analogue insensitive site at which 
the synthesis of the structural proteins (such as 
the capsid protein) is initiated. 
The relative frequency of initiation at either site is 
determined by the amount of SFV RNA present (see 
fig.2,3). 
It is attractive to make the link to the ‘in vivo’ 
situation, where during the early phase of viral infec- 
tion (with only small amounts of 42 S RNA present) 
predominantly non-structural proteins are formed. 
On the other hand, during the later stages of infection 
the synthesis of these products is gradually suppressed 
in favour of the structural products [37,38]. This 
inhibition of non-structural protein synthesis is not 
exclusively caused by the encapsidation of 42 S 
mRNA, because the nucleocapsid-negative mutant ts 
3 (incapable of encapsidating 42 S RNA) does not 
synthesize non-structural proteins in the late stage 
(high 42 S RNA concentration) of infection [39]. 
The model postulated here would provide an alterna- 
tive explanation for the occurrence of 26 S RNA late 
in infection: Preferential initiation at the internal site 
and subsequent ranslation of the structural genes 
would protect the 3’ (26 S) part of the viral messenger 
against nuclease action, whereas the non-translated 5’ 
part would be susceptible to degradation. 
The precise molecular mechanism of such a prefer- 
ential initiation remains to be elucidated. Limiting 
amounts of one or more initiation factors, like eIF- 
4A, eIF-4B and the cap-binding factor [40] might be 
one of the principal keys in the regulation. The elegant 
model of mRNA recognition, proposed [41,42], may 
be applicable to SFV RNA as far as initiation with all 
initiation factors is concerned. Alteration or lack of 
one of the factors might be a clue to open a new regu- 
latory device in order to ensure the synthesis of struc- 
tural proteins late in infection [43]. 
The results presented here bear some resemblance 
to the data obtained with Carnation Mottle virus 
RNA [44] and with Cowpea Mosaic virus RNA [45] 
in in vitro translation experiments, whereas in vivo 
experiments with Kunjin virus also indicated that its 
viral RNA may exhibit internal initiation sites [46]. 
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